Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.94)
# 159
Out of 4,690 analysts
327
Total ratings
57%
Success rate
41.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMRX Immuneering | Maintained: Buy | $14 | $4.99 | +180.56% | 2 | Aug 27, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $35 | $10.91 | +220.81% | 19 | Aug 26, 2026 | |
| NBP NovaBridge Biosciences | Reiterated: Buy | $9 | $1.84 | +389.13% | 13 | Aug 20, 2026 | |
| CADL Candel Therapeutics | Reiterated: Buy | $23 | $13.07 | +75.98% | 14 | Aug 14, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $50 | $20.45 | +144.50% | 12 | Aug 13, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $125 | $111.89 | +11.72% | 12 | Aug 13, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | $7 | $0.7535 | +829.00% | 11 | Aug 13, 2026 | |
| TARA Protara Therapeutics | Maintained: Buy | $27 | $3.83 | +604.96% | 17 | Aug 12, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $27.57 | +45.09% | 7 | Aug 12, 2026 | |
| ERAS Erasca | Reiterated: Buy | $20 → $22 | $18.03 | +22.02% | 21 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $18 | $7.40 | +143.24% | 9 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.83 | +119.18% | 14 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.33 | +177.14% | 3 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $57.80 | +12.46% | 31 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $7.22 | +149.31% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $3.80 | +163.16% | 13 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $6.00 | +116.67% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $74.34 | +34.52% | 27 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $38 | $19.54 | +94.47% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $8.05 | +86.34% | 26 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $11.03 | +81.32% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $0.9433 | +324.04% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.34 | n/a | 11 | Nov 11, 2024 |
Immuneering
Aug 27, 2026
Maintained: Buy
Price Target: $14
Current: $4.99
Upside: +180.56%
Corbus Pharmaceuticals Holdings
Aug 26, 2026
Reiterated: Buy
Price Target: $35
Current: $10.91
Upside: +220.81%
NovaBridge Biosciences
Aug 20, 2026
Reiterated: Buy
Price Target: $9
Current: $1.84
Upside: +389.13%
Candel Therapeutics
Aug 14, 2026
Reiterated: Buy
Price Target: $23
Current: $13.07
Upside: +75.98%
Sutro Biopharma
Aug 13, 2026
Reiterated: Buy
Price Target: $50
Current: $20.45
Upside: +144.50%
Monopar Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $125
Current: $111.89
Upside: +11.72%
TScan Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $7
Current: $0.7535
Upside: +829.00%
Protara Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $27
Current: $3.83
Upside: +604.96%
Immunome
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $27.57
Upside: +45.09%
Erasca
Aug 12, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $18.03
Upside: +22.02%
Aug 12, 2026
Reiterated: Buy
Price Target: $24 → $18
Current: $7.40
Upside: +143.24%
Aug 12, 2026
Reiterated: Buy
Price Target: $4
Current: $1.83
Upside: +119.18%
Aug 10, 2026
Reiterated: Buy
Price Target: $12
Current: $4.33
Upside: +177.14%
Aug 10, 2026
Maintained: Buy
Price Target: $65
Current: $57.80
Upside: +12.46%
Aug 7, 2026
Reiterated: Buy
Price Target: $18
Current: $7.22
Upside: +149.31%
Aug 7, 2026
Maintained: Buy
Price Target: $10
Current: $3.80
Upside: +163.16%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $6.00
Upside: +116.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $74.34
Upside: +34.52%
Aug 5, 2026
Reiterated: Buy
Price Target: $40 → $38
Current: $19.54
Upside: +94.47%
Aug 4, 2026
Reiterated: Buy
Price Target: $15
Current: $8.05
Upside: +86.34%
Aug 4, 2026
Reiterated: Buy
Price Target: $20
Current: $11.03
Upside: +81.32%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $0.9433
Upside: +324.04%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $5.34
Upside: n/a